28 Sep LATEST NEWS: World’s first four dimensional post-COVID lung imagery provides new insight into long-term effects of disease
This XV Technology developed in Australia provides far greater insight into the residual physiological effects of COVID-19 than can be obtained using established imaging methods and lung function tests that may not detect evidence of this prevalent condition.
“Using XV Technology, physicians can detect areas of high and low ventilation with pinpoint accuracy across all parts of the lung, in all phases of the breath”, said Dr Ray Casciari, a pulmonary physician highly experienced in interpreting four-dimensional scans, based at the St Joseph Hospital in Orange, California.
“The resulting ventilation report provides clinicians with a colour-coded and dynamic visualisation of the patient’s lung, enhanced with four-dimensional animation,” Dr Casciari added. “This report is extremely clear and easily understood, and I can use this to inform my own analysis and to show the effect of COVID to the patient.”
“Until now, much of the attention to COVID has been around the epidemiology of its spread, and more recently regarding the effect of vaccines”, said Dr Andreas Fouras, Chief Executive Officer of 4DMedical. “Health authorities are increasingly focusing on how to assess, understand and manage the lingering effects of COVID upon people who have been afflicted with the condition.
interventions for the treatment of those residual effects of COVID. Patients and their doctors have never been able to see lungs with this level of richness and details before.”